Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Equity, Diversity, and Inclusion
    • Without Borders
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Equity, Diversity, and Inclusion
    • Without Borders
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Harm/ risk (analysis)

Latest Articles

  • Views & Reviews
    The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future
    Davide Martino, Wissam Deeb, Joohi Jimenez-Shahed, et al.
    Neurology February 16, 2021
  • Article
    Thromboembolic risk with IVIgIncidence and risk factors in patients with inflammatory neuropathy
    Mahima Kapoor, Jennifer Spillane, Christina Englezou, et al.
    Neurology December 18, 2019
  • Article
    Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
    Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.
    Neurology September 12, 2019
  • Editorial
    Dosing interval of natalizumab in MSDo good things come to those who wait?
    David B. Clifford, Kenneth L. Tyler
    Neurology September 12, 2019
Show more
Advertisement
  • Neurology Podcast - Over 16 million downloads!
    TIA: Admit or Follow Up?; Update in Epilepsy Part 4
    Will Rondeau speaks with Dr. Sidsel Hastrup about inpatient vs outpatient management of TIA and stroke. Dr. Fabio Nascimento talks with Dr. Atul Maheshwari in the final part of our four-part series called Update in Epilepsy.
    February 23, 2021 Issue
    Neurology, Journal, Podcast
    Listen19:41
    Disclosures
    View Recent Podcasts
Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise